IBR Inc. has a longstanding experience in development, validation and operating cell-based assays. Our special expertise are bioassays using primary cells. These cells are isolated from a broad variety of human or mammalian tissues.
Depending on the application, primary cells are considered to deliver more physiological responses than transformed cell lines. However, primary cells are demanding with regard to cell culture and handling. The IBR Inc. scientists have vast know-how in management of primary cells to provide you with reliable and precise potency assays as well as mode of action assessments.
In addition, IBR Inc. offers bioassays using transformed cell lines and reporter gene assays. The services of IBR Inc. include a broad variety of endpoints like cell growth / apoptosis, cell signaling, migration & invasion, adhesion and many more.
The broad panel of IBR Inc.'s cell-based assays supports your drug developmental program from pre-clinical to clinical development. The cell-based assay services are also provided under the GxP Quality standards.
IBR Inc. invites you to discuss your special needs with our experts.